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RAR inhibitorMice deﬁcient in growth differentiation factor 11 (GDF11) signaling display anterior transformation of axial
vertebrae and truncation of caudal vertebrae. However, the in vivo molecular mechanisms by which GDF11
signaling regulates the development of the vertebral columnhave yet to be determined.We found thatGdf11 and
Acvr2b mutants are sensitive to exogenous RA treatment on vertebral speciﬁcation and caudal vertebral
development. We show that diminished expression of Cyp26a1, a retinoic acid inactivating enzyme, and
concomitant elevation of retinoic acid activity in the caudal region of Gdf11−/− embryos may account for this
phenomenon. Reduced expression or function of Cyp26a1 enhanced anterior transformation of axial vertebrae in
wild-type and Acvr2bmutants. Furthermore, a pan retinoic acid receptor antagonist (AGN193109) could lessen
the anterior transformation phenotype and rescue the tail truncation phenotype of Gdf11−/− mice. Taken
together, these results suggest thatGDF11 signaling regulates development of caudal vertebrae and is involved in
speciﬁcation of axial vertebrae in part bymaintaining Cyp26a1 expression, which represses retinoic acid activity
in the caudal region of embryos during the somitogenesis stage.Lee Gil Ya Cancer and Diabetes
7-45 Songdo-dong, Yunsu-gu,
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The vertebral column consists of vertebrae, which protect the spinal
cord and provide articulation for movement. Depending on the position
and morphological characteristics along the anteroposterior (AP) axis,
vertebrae are grouped into cervical, thoracic, lumbar, sacral and caudal
vertebrae. The thoracic vertebrae are characterized by the attachment of
ribs, and the sacral vertebrae are characterized by the formation of the
sacrum. In mammals, from whales to giraffes, the number of cervical
vertebrae is invariably seven except for a few species. The number of
vertebrae in thoracic, lumbar and sacral regions in mammals is almost
invariable within a species but considerably varies between species. For
instance, mice have seven cervical (C), thirteen thoracic (T), six lumbar
(L), four sacral (S), and over 20 caudal vertebrae, as represented by the
C7T13L6S4 vertebral pattern, whereas the human, chimp and horsevertebrae display C7T12L5S5, C7T14L3S5 and C7T18L6S5 patterns,
respectively. The vertebral pattern represents the hallmark of the
metameric body plan along the AP axis that provides spatial cues for the
development of the diaphragm and segmental structures such as the
axial muscles, intercostal blood vessels, and projections of spinal nerve
systems.
Each vertebra is formed from two adjacent pairs of somites, which
also form occipital bones and ribs (Saga and Takeda, 2001). Nascent
somites are added to the last segmented somite at a relatively constant
rate (about 2 hours in mice) from the presomitic mesoderm (PSM)
region, while new mesoderm is concomitantly added at the posterior
endof PSM from the tail bud. Themanner inwhich somites acquire their
positional information along the AP axis to exhibit their distinctive
morphological characteristics has been studied extensively (Baker et al.,
2006; Gregg, 2007; Saga and Takeda, 2001). Transplantation experi-
ments in chickens have shown that vertebral speciﬁcation is established
in the PSM region before the segmental plates bud off the PSM and
develop into structurally identiﬁable nascent somites (Nowicki and
Burke, 2000). Ample comparative and genetic studies have shown that a
speciﬁc array ofHox genes (a Hox code) is crucial for the speciﬁcation of
a vertebra (Wellik, 2007). Among Hox genes, Hox10 and Hox11
paralogous genes have been shown to play a role in suppressing rib
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sacrum, respectively (Carapuco et al., 2005;Wellik and Capecchi, 2003).
Activities of theseHoxgenes in the PSM, butnot in somites, are sufﬁcient
for global vertebral patterning (Carapuco et al., 2005). However, the
molecular mechanism by which a segmental plate acquires a speciﬁc
Hox code is poorly understood.
Studieswith gain- or loss-of-functionmutations inmice have shown
that a number of genes are involved in the regulation of multiple Hox
genes and thereby affect vertebral patterning (Mallo et al., 2009). These
genes include the CDX family transcription factors (van den Akker et al.,
2002), Polycomb group global gene regulators (Akasaka et al., 2001;
Core et al., 1997), proteins involved in retinoic acid (RA) synthesis,
metabolism, and signaling (Abu-Abed et al., 2001, 2003; Allan et al.,
2001; Kessel, 1992; Kessel and Gruss, 1991; Sakai et al., 2001), and
proteins involved in GDF11 signaling (Andersson et al., 2006;
McPherron et al., 1999; Oh and Li, 1997; Szumska et al., 2008). In this
paperwe focus on the interactions between RAmetabolism and GDF11,
two signaling systems involved in vertebral patterning.
Exogenous administration of RA to pregnant females at 8.5 days
post coitum (dpc) induces the posterior shift of the Hox code and
anterior transformation of vertebrae, resulting in C7/T14/L6 or C7/
T15/L5 patterns (Kessel and Gruss, 1991). Homeostasis of RA activity
in the caudal region of embryo is essential for the vertebral patterning
and the development of caudal vertebrae. In normal mice, RA is
inactivated in the caudal region by a cytochrome P450 enzyme,
CYP26A1, which catabolizes RA to 4-hydroxy RA (White et al., 1996;
Pearlmann, 2002). Repression of RA is essential for the expression of a
number of genes, such as Wnt3a, Fgf8 and bracyury, in the tail bud
region (Abu-Abed et al., 2001, 2003; Sakai et al., 2001). Mice deﬁcient
in Cyp26a1 exhibit markedly elevated RA activity in the tail bud,
homeotic transformation of vertebrae, and caudal agenesis (Abu-
Abed et al., 2001, 2003; Sakai et al., 2001). Moreover, RA receptor
deﬁciency can rescue the axial vertebral defects of Cyp26a1-null mice,
demonstrating that elevated RA in the caudal region is the cause of the
vertebral defects in Cyp26a1−/− mice (Abu-Abed et al., 2003).
GDF11 is a member of the transforming growth factor-β (TGF-β)
superfamily and is involved in axial vertebral patterning and
development of the palate, kidney, and pancreas (Dichmann et al.,
2006; Esquela and Lee, 2003; McPherron et al., 1999). The active form
of TGF-β superfamily proteins is generated by proteolytic cleavage of
the precursor protein. Recent studies have shown that proprotein
convertase PCSK5 (PC5/6) is necessary for the activation of Gdf11
(Essalmani et al., 2008; Seidah et al., 2008; Szumska et al., 2008). The
TGF-β family signal is transduced through interactions with hetero-
meric complexes of type II and type I receptors (Massague, 1998).
Activin type II receptors (ACVR2A and ACVR2B) and the TGF-β type I
receptor (ALK5; TGFBR1) have been shown to mediate the GDF11
signal for vertebral speciﬁcation (Andersson et al., 2006; Oh and Li,
1997; Oh et al., 2002). SMAD2 and SMAD3 are known cytoplasmic
targets of ACVR2/2B and ALK5 (Massague, 1998; Oh et al., 2002).
Gdf11−/− mice exhibit anterior transformations of the axial
skeleton, resulting in an increased number of thoracic and lumbar
vertebrae (C7/T18/L8) and truncation of caudal vertebrae (McPher-
erron et al., 1999). GDF11 has functional redundancy with GDF8
(myostation; Mstn) in patterning and development of the axial
skeleton (McPherron et al., 2009): most Gdf11−/−;Mstn−/− mice
have an increase in severity of anterior transformation (mostly 20
thoracic vertebrae) and tail truncation (up to sacral vertebrae), as
compared to Gdf11−/− mice. The vertebral transformation defects of
Gdf11−/−;Mstn−/− mice represent the most remarkable phenotype
among all known vertebral patterning defects of multiple mutantmice
in terms of the extent of the transformation. The closest phenotypic
resemblance is found in mice with triple Hox gene deletion (Wellik
and Capecchi, 2003;McIntyre et al., 2007), suggesting that expressions
of multiple Hox genes are affected in Gdf11−/− mice. Consistent with
this, it has been demonstrated that the expression boundaries ofmultiple Hox genes are shifted posteriorly in Acvr2b−/−, Gdf11−/−, and
Pcsk5−/−mice (Essalmani et al., 2008; McPherron et al., 1999; Oh and
Li, 1997; Szumska et al., 2008). However, the mechanism by which
Gdf11 signaling controls multiple Hox genes for axial vertebral
patterning remains unknown.
In this paper, we present data suggesting that GDF11 signaling is
an important determinant for the RA gradient along the AP axis by
regulating CYP26A1 expression in the tail bud region for proper
vertebral speciﬁcation and tail development.
Materials and methods
Mouse strains
All mouse strains used in this study are listed as follows: Gdf11-,
Acvr2a-, Acvr2b-, Cyp26a1-knockout mice, and RARE-LacZ transgenic
mice (McPherron et al., 1999; Oh and Li, 1997; Rossant et al., 1991;
Sakai et al., 2001; Song et al., 1999; Yang et al., 1999). Mice were
maintained under standard speciﬁc-pathogen-free conditions and all
animal procedures performed were reviewed and approved by the
University of Florida and Johns Hopkins University School of Medicine
Institutional Animal Care and Use Committee.
Mouse mating schemes
For monitoring the in vivo RA activity, Gdf11+/−;RARE-lacZ(+)
and Acvr2b+/−;RARE-lacZ(+)maleswere intercrossedwithGdf11+/−
andAcvr2b+/−females,respectively.EmbryoswerecollectedatE8.5and
E10.5 for X-gal staining. For genetic interaction between Acvr2b and
Cyp26a1, Acvr2b−/− males were intercrossed with Acvr2b+/−;
Cyp26a1+/− females, and the vertebral patterns of Acvr2b−/−;
Cyp26a1+/− newborn pups were compared with those of Acvr2b−/−
and Acvr2b+/−;Cyp26a1+/− pups. For the RA sensitivity study,
Acvr2b−/− males were intercrossed with Acvr2b+/−;Acvr2a+/−
females. RA was administered to dams at 8.5 dpc as described below.
Administration of R115866, retinoic acid, and AGN193109
10 mM R115866 (Johnson & Johnson Co.) stock was made in
DMSO and the aliquots were stored in −20 °C freezer. The stock
solution was diluted in PEG200 just prior to use and administered to
pregnant dams at 8.5 dpc via oral gavage needles. All-trans RA (Sigma-
Aldrich, St. Louis, MO) was dissolved in DMSO at 25 mg/ml and stored
at−20 °C in the dark. The RA stock solutionwas subjected to a 10-fold
dilution in sesame oil and orally administrated to the pregnantmice at
8.5 dpc at a ﬁnal concentration of 10 mg/kg of body weight.
AGN193109 (Allergan Inc., Irvine, CA) was dissolved in DMSO at
1 mg/ml and stored at−20 °C freezer. The stock solution was diluted
in corn oil just before use and administrated to pregnant dams at 8.5
and/or 9.5 dpc through oral gavage needles at a ﬁnal concentration of
2 mg/kg of body weight.
Skeleton preparation
E17.5, E18.5, or newborn pups were subjected to skeleton
preparations as previously described (Lee et al., 2006). Mice were
eviscerated and left in water overnight with gentle shaking. After
further removal of skin, fat, muscle, and glands, the sample was ﬁxed
in 95% ethanol for 2 to 5 days. The sample was then stained overnight
in Alcian blue 8GX staining solution (0.15 mg/ml in 80% ethanol and
20% glacial acetic acid), and rinsed with 95% ethanol. After the tissue
debris was cleared in 2% KOH solution for 3 hr, the skeleton was
stained with 0.005% alizarin red S in 2% KOH for 3 h. The stained
skeleton was rinsed with 2% KOH and kept in 50% glycerol/PBS.
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To detect RA activities in E9.5 or E10.5 embryos, whole-mount X-gal
staining was carried out as described previously (Joo et al., 2007).
Brieﬂy, collected embryos were ﬁxed in ﬁxing solution (1% formalde-
hyde, 0.2% glutaraldehyde, 2 mM MgCl2, 5 mM EGTA, 0.02% NP-40 in
PBS), rinsed three timeswith PBS, and stained in X-gal staining solution
[5 mM K3Fe(CN)6, 5 mM K4Fe(CN)6, 2 mM MgCl2, 0.01% Deoxycholate
sodium salt, 0.02% NP-40, 0.75 mg/ml X-gal in 100 mM phosphate
buffer (pH7.3)] at 37 °C overnight. Stained embryos were post-ﬁxed in
post-ﬁxing solution (4% paraformaldehyde, 0.1% Tween 20 in PBS) at
4 °C overnight.
Whole-mount in situ hybridization
For studying the expression patterns of MesP2, Aldh1a2, Gdf11,
Cyp26a1, Fgf8, and Wnt3a in E9.0, E9.5 or E10.5 embryos, antisense
RNA probes were produced by using a digoxigenin-UTP labeling kit
(Roche Diagnostics Corporation, Indianapolis, IN). The MesP2 (Saga
et al., 1997), Aldh1a2 (Niederreither et al., 1997), Gdf11 (McPherron
et al., 1999), and Fgf8 (Mahmood et al., 1995) probes were generated
from the template DNAs as described previously. The Cyp26a1 and
Wnt3a probes were obtained from Cyp26a1 EST clone (IMAGE clone
No.:6334777) and Wnt3a cDNA (NM_009522, nt1180-2266), respec-
tively. Whole-mount in situ hybridization was performed as previ-
ously described (Wilkinson, 1992). Genomic DNA isolated from yolk
sac was used for genotyping embryos.
Results and discussion
Acvr2b and Gdf11 mutants are sensitive to exogenous RA treatment
Exposure of embryos to all-trans RA at a high dose (100 mg/kg bw) at
8.5 dpc has been shown to induce anterior transformations of vertebrae,
resulting in C7/T14/L6 or C7/T15/L5 patterns with varied degrees of tail
truncation (Kessel andGruss, 1991; Kessel, 1992).We showedpreviouslyFig. 1. Acvr2a/b andGdf11mutants are sensitive to exogenous RA exposure. Representative ven
(F–H) fetuses exposed to either sesame oil (A, C, F) or RA (B, D, E, G, H) in utero at 8.5 dpc (10
colored boxes in each panel indicate a represented number of cervical (C; red), thoracic (T; b
truncations of the axial skeletons occurred posterior to mid-lumbar region in RA exposed Acvrthat RA treatment of Acvr2b−/− embryos at 8.5 dpc with a low dose
(10 mg/kg bw), which only moderately induces vertebral patterning
defects inWTmice, intensiﬁed vertebral defects, resulting in a C7/T18/L6
pattern with truncation of tail (Oh and Li, 1997), indicating that mice
deﬁcient in ACVR2B signaling are sensitive to exogenous RA exposure.
Because the vertebral patterning defect in Acvr2b−/−mice (C7T16L6) is
milder than that seen in Acvr2a+/−;Acvr2b−/−mice (C7T17L7; Oh et al.,
2002), Gdf11−/− mice (C7T18L8; McPherron et al., 1999) or Gdf11−/−;
Mstn−/− mice (C7T20L8; McPherron et al., 2009), we sought to
determine whether RA could have a similar exacerbating effect in
embryos with a more severe patterning phenotype.
As shown in Fig. 1, RA increased theextent of transformations in both
activin type II receptor compound mutant and Gdf11−/− mice. RA-
treated Acvr2a+/−;Acvr2b−/−mice had further increases in the number
of thoracic vertebrae (up to 20)with severe truncation of lumbar, sacral
and caudal vertebrae (Fig. 1A, B). RA treatment of Gdf11−/− mice
also resulted in increased thoracic vertebral number to T20 with
reduced numbers of lumbar vertebrae and no sacral/caudal vertebrae
(Fig. 1C, D). The vertebral patterns of the RA-treated Gdf11−/− and
Acvr2a+/−;Acvr2b−/− mice are remarkably similar to each other and
also very similar to those of Gdf11−/−;Mstn−/−mice (McPherron et al.,
2009). Interestingly, Gdf11+/−mice also showed a higher sensitivity to
the RA treatment compared to their WT littermates. RA treatment
(10 mg/kg bw) caused typical thoracolumbar transformations in both
Gdf11+/+ and Gdf11+/− mice, but at a higher frequency in Gdf11+/−
mice (19/20) compared to Gdf11+/+ mice (6/17). Moreover, RA
reduced the number of caudal vertebrae by about 3 in Gdf11+/+ mice
(untreated vs. treated: 28±2 vs. 25±7) compared to about 13 in
Gdf11+/− mice (30±2 vs. 17±8).
These results clearly demonstrate that mice deﬁcient in GDF11-
ACVR2 signaling are sensitive to exogenous RA exposure. Phenotypic
overlap (i.e. severe caudal truncation and anterior transformation)
amongGdf11−/−;Mstn−/−mice (McPherron et al., 2009), high doseRA-
treated WT embryos (Kessel, 1992), and low dose RA treated Acvr2a/b
andGdf11mutants (Fig. 1) suggestedamechanistic linkbetweenRAand
GDF/ACVR2 signaling for vertebral patterning and tail development.tral view of axial skeletons ofwild-type (A, B), Acvr2a+/−;Acvr2b−/− (C–E), andGdf11−/−
mg/kg of body weight). Limbs were removed during skeleton preparation. Diagram with
lue), lumbar (L; orange), sacral (S; green), and caudal (Cd; dark blue) vertebrae. Severe
2mutants and Gdf11−/− fetuses.
Fig. 2. Gdf11 expression domain overlaps with Cyp26a1 expression in the PSM region. Whole mount in situ hybridization of Aldh1a2 (A), Cyp26a1 (B), and Gdf11 (C) in wild-type
embryos at E9.0–E9.5 revealed that Gdf11 expression in the PSM region (indicated by orange lines) overlaps with Cyp26a1 but mutually exclusive with Aldh1a2 expression. MesP2
expression is indicated by an arrow head (C).
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embryos
RA levels along the AP axis are tightly regulated by speciﬁc
distribution of both RA-synthesizing and RA-inactivating enzymes.
During critical stages of somitogenesis for thoracic and lumbar
vertebral development (E8.5-E10.5), the RA-synthesizing enzyme,
ALDH1A2 (aldehyde dehydrogenase family 1 subfamily A2), is
predominantly expressed in somites and lateral plate mesoderm but
not in the presomitic and tailbud region (Fig. 2A) (Niederreither et al.,
1997). Conversely, the RA-inactivating enzyme, CYP26A1, is
expressed predominantly in the presomitic and tail bud region
(Fig. 2B) (Sakai et al., 2001). This reciprocal expression pattern of
RA-synthesizing and -inactivating enzymes may generate a gradient
of RA activity along the AP axis, with diminishing RA levels toward the
caudal end. The expression domain of Cyp26a1 overlaps with that of
Gdf11, which is expressed in the tail bud and the PSM but not in
mature somites (Fig. 2C) (Andersson et al., 2006; Nakashima et al.,
1999). We investigated whether the Cyp26a1 expression is affected in
Gdf11−/− embryos at the caudal region by whole mount in situ
hybridization (WISH) on E9.5 and E10.5 WT and Gdf11−/− embryos
using a Cyp26a1 anti-sense probe. As shown in Fig. 3G, Cyp26a1Fig. 3. Altered expression of Cyp26a1 and Wnt3a in Gdf11−/− embryos. Whole-mount in
antisense-Cyp26a1, -Wnt3a, and -Fgf8 probes. Insets are the magniﬁed views of the PSM
(arrowhead) regions of Gdf11−/− embryos.transcripts were reduced and detected only at the tail tip region in
E9.5 Gdf11−/− embryos. A similar pattern with a more dramatic
difference of expression level was observed in E10.5 Gdf11−/−
embryos in comparison with their WT littermates (Fig. 3B, H). A
number of reports have shown that expression of Fgf8 or Wnt3a,
important regulators of the somitogenesis, segmentation clock and
caudal development, is repressed in the tail bud region of Cyp26a1−/−
embryos (Abu-Abed et al., 2001, 2003; Baker et al., 2006; Gregg, 2007;
Sakai et al., 2001). To determine whether the expression levels of
these genes were also affected in Gdf11−/− embryos, we performed
WISH using Fgf8 andWnt3a anti-sense probes. TheWnt3a expression
appeared to be slightly reduced in E9.5 and markedly diminished in
E10.5 Gdf11−/− embryos (Fig. 3I, J). However, the level of Fgf8
expression did not appear to be signiﬁcantly affected in E9.5 and E10.5
Gdf11−/− embryos (Fig. 3K, L).
In vivo RA activity gradient is altered in Gdf11-null embryos
To investigate whether the reduced and posteriorly shifted
Cyp26a1 expression domain in Gdf11−/− embryos affects RA activity
along the AP axis in Acvr2b and Gdf11 mutants, we examined the
in vivo RA activity in Acvr2b−/−, Gdf11−/−, and control embryos usingsitu hybridization on E9.5 and E10.5 of WT (A–F) and Gdf11−/− (G–L) embryos using
/tailbud area. Note the reduced expression of Cyp26a1 and Wnt3a in the tail bud
Fig. 4. Posteriorized RA activities in the caudal region of the Gdf11−/− embryos. RA activities were visualized by X-gal staining in RARE-LacZ(+);Gdf11+/− (A), RARE-LacZ(+);Acvr2b−/− (B),
and RARE-LacZ(+);Gdf11−/− (C) E10.5 embryos. Lower panels aremagniﬁed views of posterior regions of the corresponding embryo. Asterisks and arrows indicate the posterior-most X-gal
positive somite and MesP2 expression, respectively. MesP2 marks for the junction between the posterior-most somite and the PSM region.
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expression is regulated by retinoic acid response elements (RARE)
(Rossant et al., 1991). E10.5 control andmutant embryoswere stained
with X-gal followed by WISH with an MesP2 anti-sense probe
(Takahashi et al., 2000) to visualize the junction between the PSM
and the ﬁrst mature somite (S0). In WT, Acvr2b+/−, and Gdf11+/−
embryos, the posterior-most X-gal positive somite was found on 9th,
10th, or 11th mature somite (S9-S11) (Fig. 4A). The RA activity
domain in Acvr2b−/− embryos was extended slightly posteriorly
compared to that in WT embryos, in which the posterior-most X-gal
positive somite was detected on S7-S8 (Fig. 4B). However, a dramatic
posterior shift of the RA activity domain was observed in Gdf11−/−
embryos (Fig. 4C). In most cases, RA activity was detected on S0 near
the rostral end of the PSM.Fig. 5. Impaired inactivation of RA activities in the nascent somites of Gdf11−/− embryos
difference between Gdf11+/− (A, A') and Gdf11−/− (B, B') embryos at E9.5. RA activities we
embryos (D, D') at E10.0. Asterisks and arrows indicate the posterior-most X-gal positive sTo investigate the timing of this caudal-shift, we examined the
pattern of RA activity in earlier stages of WT and Gdf11−/− embryos.
As shown in Fig. 5A and B, the posterior-most X-gal positive somite
was found at S1 in both control (n=4) and Gdf11−/− embryos (n=7)
at E9.5. At E10.0, RA activity was undetectable in nascent somites of
control embryos, as the posterior-most X-gal positive somite was
detected in S4 (Fig. 5C, C'), whereas RA activity was detected in
nascent somites of Gdf11−/− embryos (n=2) (Fig. 5D, D'). These
results demonstrate that RA activity is progressively shifted in the
anterior direction, (i.e., RA activity is inhibited in nascent somites) in
the period between E9.5 and E10.5 in WT embryos, whereas this
anterior shift of the RA activity domain did not occur in Gdf11−/−
embryos. Taken together, these results suggest that down-regulation
of Cyp26a1 expression in the PSM region of Gdf11−/− embryosduring E9.5–E10 stages. RA activities visualized by X-gal staining have no apparent
re shown to be shifted to the rostral direction in Gdf11+/− (C, C') but not in Gdf11−/−
omite and MesP2 expression, respectively.
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stages, resulting in an expansion of the RA activity domain to the
caudal region of Gdf11−/− embryos.
Although the RA activity did not appear to be greatly affected in
Acvr2b−/− embryos (Fig. 4B), we investigated the possibility that the
hypersensitivity of Acvr2b−/− and Acvr2a+/−;Acvr2b−/− embryos to
exogenous RA treatment (Fig. 1) (Oh and Li, 1997) might reﬂect
differences in levels of Cyp26a1 expression inmutant embryos. To test
this, we examined the RA activity in E10.5 Acvr2b+/− and Acvr2b−/−
embryos treated with RA at 8.5 dpc. As shown in Fig. 6A, exogenous
RA treatment did not alter the RA activity domain in Acvr2b+/− orWT
(data not shown) embryos. However, the RA treatment shifted the RA
activity domain in the posterior direction in Acvr2b−/− embryos
(Fig. 6C).Reduced expression or activity of Cyp26a1 affects vertebral patterning
It has been shown that Cyp26a1−/− mice display severe trunca-
tions of tail vertebrae and a mild vertebral patterning defect
represented by a C6T14L5 or C6T15L5 pattern that includes a
posterior transformation in the cervicothoracic transition and an
anterior transformation in the thoracolumbar transition (Abu-Abed
et al., 2001; Sakai et al., 2001). Hence, the vertebral speciﬁcation
defects of Cyp26a1−/− mice are very different from those of Gdf11−/−
mice. Together with our expression data showing that Cyp26a1
expression is reduced or posteriorly shifted but not absent in
Gdf11−/− embryos (Fig. 3G, H), these ﬁndings suggested that the
vertebral phenotype in Gdf11−/− mice may in part be due to
dysregulation rather than complete repression of Cyp26a1. In order
to investigatewhether a reduction in expression or activity of CYP26A1
can affect vertebral patterning and/or development of tail vertebrae,
we employed both genetic and pharmacological approaches.
The vertebral phenotype of Acvr2b−/−mice is sensitive to additional
mutationof genes in the sameor counteracting signalingpathwayandcan
be either alleviated or intensiﬁed depending on further inhibition of BMP
or GDF11 signaling, respectively (Andersson et al., 2006; Oh et al., 2002;
Park et al., 2004). Therefore, we examined possible genetic interactions
between Acvr2b and Cyp26a1 by comparing the vertebral patterns of
Acvr2b−/−;Cyp26a1+/− newborn pups with those of Acvr2b−/− and
Acvr2b+/−;Cyp26a1+/− littermates (Supplemental Fig. 1). Out of nineFig. 6. RA activities of the Acvr2b−/− embryos are sensitive to exogenous RA exposure. In vivo
Acvr2b−/− (B), and RA-treated RARE-lacZ(+);Acvr2b−/− (C) E10.5 embryos exposed to RA (or
Asterisks and arrows in the low panels indicate the posterior-most X-gal positive somite andMlitters, we have obtained eight Acvr2b+/−;Cyp26a1+/−, nine Acvr2b−/−,
and ten Acvr2b−/−;Cyp26a1+/− mice. All eight double heterozygous
pups and eight out of nine Acvr2b−/− pups exhibited the normal
C7T13L6 pattern and the typical C7T16L6 pattern, respectively. Six out of
ten Acvr2b−/−;Cyp26a1+/− pups, however, exhibited partial lumbar to
thoracic transformation at V24 and therefore exhibited a C7T17(s)L5
pattern.
As an alternative approach, we attempted to reduce the CYP26A1
activity by administering a pharmacological inhibitor of CYP26
enzymes, R115866 (Johnson & Johnson Co). It has been shown that
oral administration of this compound into rats can alter levels of RA
signaling in vivo (Stoppie et al., 2000). It has never been tested, however,
whether this compound can efﬁciently inhibit Cyp26 enzymes in
embryos andwhether such inhibitionwould affect vertebral patterning.
We ﬁrst examined the effect of administering the drug toWT pregnant
dams at 8.5 dpc via oral gavage in various concentrations ranging from
2.5 to 20 mg/kg of bw. At 20 mg/kg bw, all nine fetuses exhibited cleft
palate and small mandible, and some also exhibited an opened-eye
phenotype (data not shown). Interestingly, seven out of nine exhibited
mild anterior transformation of vertebrae, such as C7T14L6 (n=3),
C7T14L5 (n=3), or C7T14(s)L5 (n=1) (Supplemental Fig. 2A, B).
In order to test the impact of this CYP26 inhibitor on Acvr2b−/−
background, we analyzed the vertebral patterns of E18.5 fetuses treated
with the drug (10 mg/kg bw) at 8.5 dpc. At this dosage, none of the WT
and Acvr2b+/−fetuses (n=7) exhibited vertebral defects (Supplemental
Fig. 2C), whereas Acvr2b−/− fetuses displayed more exaggerated
vertebral transformation defects in comparison with the unexposed
Acvr2b−/−mice (Supplemental Fig. 2D, E). One of treatedmicewas found
dead and exhibited the C7T18L4 pattern with a severe truncation of tail
vertebrae (Supplemental Fig. 2E). Thesegenetic andpharmacological data
provide further support for our model that dysregulation of RA
homeostasis mediated by CYP26A1 is an important contributing factor
for the axial vertebral defects observed in Acvr2b−/− and Gdf11−/−mice.Elevated RA activity is partially responsible for axial vertebral defects in
Gdf11-null mice
RA signaling is mediated by retinoic acid receptors (RARA, RARB,
and RARG) and retinoid X receptors (RXRA, RXRB, and RXRG) (Mark
et al., 2009). It has been shown that RARG is the crucial gene for axialRA activities of RA-treated RARE-lacZ(+);Acvr2b+/− (A), vehicle-treated RARE-lacZ(+);
vehicle) at 8.5 dpc were visualized by X-gal staining followedMesP2 in situ hybridization.
esP2 expression, respectively. Green dots indicate the segmented somites.
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and Rarg-deletion has been shown to rescue the vertebral defects of
Cyp26a1−/−mutants (Abu-Abed et al., 2003). In order to evaluate the
extent to which impaired RA homeostasis affects the vertebral defects
in Gdf11−/−mice, we attempted to block the RA signaling using a pan
retinoic acid receptor antagonist, AGN193109 (Johnson et al., 1995;
Agarwal et al., 1996). We analyzed axial skeletons of E18.5 WT and
Gdf11−/− fetuses treated with AGN193109 at 8.5 and/or 9.5 dpc, a
crucial developmental period for vertebral speciﬁcation and tailFig. 7. Tail truncation defects of Gdf11−/−mice are signiﬁcantly rescued by a pan retinoic acid r
(lower panels) views of posterior lumbar, sacral, and proximal caudal vertebrae are shown. All
arrows indicate the ﬁrst sacral vertebra. (A)WT treatedwith AGN. Red dotswith a bracket indic
caudal vertebrae that do not contain transverse and spinous processes. (B) AGN-treated Cyp26
Cyp26a1−/− fetuses. The morphological transition in the caudal vertebrae is also restored (inse
two consecutive days at 8.5 and 9.5 dpc. AGN-treated Gdf11−/− embryos show elongated tail.
(indicated by red dots). (E, F) Gdf11−/− skeletons treatedwith AGN at 8.5 dpc (E) and 9.5 dpc (
present posterior to 4th sacral vertebra. Means and standard deviations are shown as ﬁlled b
compared with vehicle-treated Gdf11−/− embryos as determined by Student's t test. ** (pb0.0development. Most WT embryos treated with vehicle or AGN193109
(oral administration, 2 mg/kg of bw) at 8.5 dpc exhibited the normal
vertebral pattern (C7T13L6) and had 24–29 caudal vertebrae
(average: 27 caudal vertebrae; Fig. 7A; Supplemental Fig. 3A, B).
Although the posterior transformation phenotype at the cervicothor-
acic junction was unaffected, treatment with the drug could almost
completely rescue the caudal defects of Cyp26a1−/−mutants (Fig. 7B;
Supplemental Fig. 3C, D), demonstrating the effectiveness of
this regimen. Vehicle-treated Gdf11−/− embryos showed typicaleceptor antagonist, AGN193109 (AGN). Representative ventral (upper panels) and lateral
skeletons were collected from E18.5 fetuses, except for Cyp26a1−/− from E17.5 (B).White
ate proximal caudal vertebrae having transverse and spinous processes. Asterisks indicate
a1−/− skeletons. AGN treatment almost completely rescued the caudal agenesis defect of
t). (C) Vehicle-treated Gdf11−/− skeletons. (D) Gdf11−/− skeletons treated with AGN for
Take notice that the extended caudal vertebrae contain transverse and spinous processes
F). (G) Histogram showing the number of caudal vertebrae, deﬁned as vertebral segments
ox and bar above each box, respectively. * (pb0.0001), # (pb0.001), and ## (pb0.01):
5) compared with AGN-treated Gdf11−/− embryos at 8.5 or 9.5 dpc.
202 Y.J. Lee et al. / Developmental Biology 347 (2010) 195–203C7T18L8 or C7T18L7 patterns with truncation of tails (average: 2.5
caudal vertebrae; Fig. 7C; Supplemental Fig. 3E, F). The treatment of
AGN193109 for two consecutive days at 8.5 and 9.5 dpc markedly
rescued the tail truncation defect of Gdf11−/− fetuses (average: 16.6
caudal vertebrae; Fig. 7D; Supplemental Fig. 3G–I). Drug treatment at
either 8.5 or 9.5 dpc could also rescue the tail truncation defect of
Gdf11−/− but to a less extent than that seen with the 2-day treatment
(average: 11 caudal vertebrae; Fig. 7E, F). The effect by the RA signaling
inhibitor in terms of rescuing the anterior transformation phenotype
of Gdf11−/−micewas not as dramatic as that seen in terms of rescuing
the tail defect, with the number of thoracic vertebrae being reduced to
17with 2 days of drug treatment (Supplemental Fig. 3G–I).We did not
include the number of lumbar vertebrae for comparison because itwas
difﬁcult to identify the ﬁrst sacral vertebra to accurately count the
number of lumbar vertebrae.
Gdf11−/− mice display defects in development of axial vertebrae,
characterized by severe anterior vertebral transformation and agenesis
of caudal vertebrae. Here we have demonstrated that regulation of RA
metabolismby CYP26A1 in the PSM/tailbud region is a key downstream
mechanism by which GDF11 signaling controls the development of
caudal vertebrae. Speciﬁcally, we showed that Gdf11−/− embryos have
diminished expression of Cyp26a1 in the tail bud region and impaired
inactivation of RA in nascent somites at E9.5 and E10.5 and that
diminished levels of CYP26A1 also correlates with hyper-sensitivity of
Acvr2a/b and Gdf11 mutant mice to exogenous RA exposure. Further-
more, we showed that treatment of embryos with a RARG antagonist
could rescue the caudal agenesis phenotype of Gdf11−/− mice.
Interestingly, the RARG antagonist rescued truncation of caudal
vertebrae of Gdf11−/−mice, but the morphology of the rescued caudal
vertebrae was abnormal. In WT mice, a morphological transition (i.e.,
absence of transverse and spinous processes) occurs at the 5th or 6th
caudal vertebra (Fig. 7A inset). Such a transition was present in the
rescued caudal vertebrae of Cyp26a1−/−mice (Fig. 7B inset) but not in
those of Gdf11−/−mice (Fig. 7D–F). Although additional studies will be
required todetermine the extent towhichother downstreammediators
are required for correct speciﬁcation of caudal vertebrae, the data
presented here strongly suggest that Cyp26a1 is an essential down-
stream target of GDF11-ACVR2 signaling and that dysregulation of RA
metabolism is at least partially responsible for the patterning defects
seen in Gdf11 mutant mice. Hence, our studies are consistent with a
direct relationship between the pathways regulated by GDF11 and by
retinoic acid in establishing positional identity along the anterior-
posterior axis and raise the possibility that these signaling pathways
may also interact in regulating other developmental processes.Acknowledgments
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